Hims & Hers Advances AI-Powered Personalized Digital Healthcare
HIMS accelerates AI-powered care with new tech leadership, personalized treatments and a major $870 million investment push.
Zacks·5d ago
More News
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
Zacks·13d ago
Hims & Hers Expands Health Access Through Subscription Revenue Model
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
Zacks·24d ago
From Apps to Nutrition: Health & Fitness Stocks to Buy Now
UNFI, AMWL, STKL, and PTON stand out as health and fitness plays, tapping into booming demand for wellness, nutrition and digital care.
Zacks·24d ago
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
Zacks·2mo ago
Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem
HIMS expands its digital health footprint with global moves, top-tier partnerships and more than 1,500 providers.
Zacks·2mo ago
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?
Hims & Hers expands globally, while Amwell leans on federal contracts and software growth. Let's see which has the edge in earnings growth & strategic expansion.
Zacks·2mo ago
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals
HIMS eyes long-term growth with new hormonal health offerings, international expansion and high GLP-1 retention.
Zacks·2mo ago
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
Zacks·3mo ago
American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.